Melatonin reduces median nerve injury-induced mechanical hypersensitivity via inhibition of microglial p38 mitogen-activated protein kinase activation in rat cuneate nucleus

Journal of Pineal Research

Volumn 54, Issue 2, 2013, Pages 232-244

  Chiang, Rayleigh Ping Ying ^a   Huang, Chun Ta ^b   Tsai, Yi Ju ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

median nerve; melatonin; neuropathic pain; p38 MAPK; pinealectomy

Indexed keywords

CD11B ANTIGEN; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CUNEATE NUCLEUS; HYPERSENSITIVITY; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MEDIAN NERVE; MICROGLIA; NERVE COMPRESSION; NERVE INJURY; NONHUMAN; PINEALECTOMY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MEDIAN NERVE; MELATONIN; NEURALGIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS;

EID: 84873448346     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12029     Document Type: Article

References (63)

1. Zimmermann M,. Pathobiology of neuropathic pain. Eur J Pharmacol 2001; 429: 23-37.
2. Woolf CJ, Mannion RJ,. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-1964.
3. Scholz J, Woolf CJ,. Can we conquer pain? Nat Neurosci 2002; 5: 1062-1067.
4. Watkins LR, Milligan ED, Maier SF,. Glial activation: a driving force for pathological pain. Trends Neurosci 2001; 24: 450-455.
5. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, et al. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004; 45: 89-95.
6. Tsuda M, Inoue K, Salter MW,. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005; 28: 101-107.
7. Watkins LR, Maier SF,. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82: 981-1011.
8. Watkins LR, Maier SF,. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2003; 2: 973-985.
9. Lin SC, Yeh JH, Chen CL, et al. Effects of local lidocaine treatment before and after median nerve injury on mechanical hypersensitivity and microglia activation in rat cuneate nucleus. Eur J Pain 2011; 15: 359-367.
10. Jin SX, Zhuang ZY, Woolf CJ, et al. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003; 23: 4017-4022.
11. Kim SY, Bae JC, Kim JY, et al. Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. NeuroReport 2002; 13: 2483-2486.
12. Hains BC, Waxman SG,. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006; 26: 4308-4317.
13. Terayama R, Omura S, Fujisawa N, et al. Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 2008; 153: 1245-1255.
14. Stehle JH, Saade A, Rawashdeh O, et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
15. Vanecek J,. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78: 687-721.
16. Hardeland R, Madrid JA, Tan DX, et al. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 2012; 52: 139-166.
17. Cardinali DP, Srinivasan V, Brzezinski A, et al. Melatonin and its analogs in insomnia and depression. J Pineal Res 2012; 52: 365-375.
18. Santhi N, Thorne HC, van der Veen DR, et al. The spectral composition of evening light and individual differences in the suppression of melatonin and delay of sleep in humans. J Pineal Res 2012; 53: 47-59.
19. Zahn PK, Lansmann T, Berger E, et al. Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation. J Pineal Res 2003; 35: 24-31.
20. Gitto E, Aversa S, Salpietro CD, et al. Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J Pineal Res 2012; 52: 291-295.
21. Wilhelmsen M, Amirian I, Reiter RJ, et al. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 2011; 51: 270-277.
22. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physiochemical examination. J Pineal Res 2011; 51: 1-16.
23. Ambriz-Tututi M, Granados-Soto V,. Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain 2007; 132: 273-280.
24. Arreola-Espino R, Urquiza-Marin H, Ambriz-Tututi M, et al. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats. Eur J Pharmacol 2007; 577: 203-210.
25. Zimmermann M,. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110.
26. Bennett GJ, Xie YK,. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
27. Tsai YJ, Lin CT, Huang CT, et al. Neuropeptide Y modulates c-Fos protein expression in the cuneate nucleus and contributes to mechanical hypersensitivity following rat median nerve injury. J Neurotrauma 2009; 26: 1609-1621.
28. Chen JJ, Lue JH, Lin LH, et al. Effects of pre-emptive drug treatment on astrocyte activation in the cuneate nucleus following rat median nerve injury. Pain 2010; 148: 158-166.
29. Tsai YJ, Huang CT, Lin SC, et al. Effects of regional and whole-body hypothermic treatment before and after median nerve injury on neuropathic pain and glial activation in rat cuneate nucleus. Anesthesiology 2012; 116: 415-431.
30. Pellegrino LJ, Pellegrino AS, Cushman AJ,. A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York, 1979; pp. 41-43.
31. Hoffman RA, Reiter RJ,. Rapid pinealectomy in hamsters and other small rodents. Anat Rec 1965; 153: 19-21.
32. Palkovits M, Brownstein MJ,. Maps and Guide to Microdissection of the Rat Brain. Elsevier, New York, 1988; pp. 199-204.
33. Tal M, Bennett GJ,. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain 1994; 57: 375-382.
34. Ji RR, Suter MR,. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007; 3: 33.
35. Xu L, Huang Y, Yu X, et al. The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury. Anesth Analg 2007; 105: 1838-1844.
36. Koistinaho M, Koistinaho J,. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 2002; 40: 175-183.
37. Svensson CI, Schafers M, Jones TL, et al. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett 2005; 379: 209-213.
38. Zhuang ZY, Gerner P, Woolf CJ, et al. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114: 149-159.
39. Zhuang ZY, Wen YR, Zhang DR, et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006; 26: 3551-3560.
40. Deleo JA, Yezierski RP,. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001; 90: 1-6.
41. Hanisch UK,. Microglia as a source and target of cytokines. Glia 2002; 40: 140-155.
42. Tikka T, Fiebich BL, Goldsteins G, et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001; 21: 2580-2588.
43. Koistinaho M, Kettunen MI, Goldsteins G, et al. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci USA 2002; 99: 1610-1615.
44. Widmann C, Gibson S, Jarpe MB, et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-180.
45. Färber K, Kettenmann H,. Functional role of calcium signals for microglial function. Glia 2006; 54: 656-665.
46. Lue JH, Jiang-Shieh YF, Shieh JY, et al. Multiple inputs of GABA-immunoreactive neurons in the cuneate nucleus of the rat. Neurosci Res 1997; 27: 123-132.
47. Lue JH, Chen SH, Shieh JY, et al. Afferent synaptic contacts on glycine-immunoreactive neurons in the rat cuneate nucleus. Synapse 2001; 41: 139-149.
48. Kim WK, Ko KH,. Potentiation of N-methyl-D-aspartate-mediated neurotoxicity by immunostimulated murine microglia. J Neurosci Res 1998; 54: 17-26.
49. Lohr C, Deitmer JW,. Calcium signaling in invertebrate glial cells. Glia 2006; 54: 642-649.
50. Ben-Menachem E,. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004; 45: 13-18.
51. Wodarski R, Clark AK, Grist J, et al. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur J Pain 2009; 13: 807-811.
52. Naguib M, Hammond DL, Schmid PG 3rd, et al. Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth 2003; 90: 504-507.
53. Raghavendra V, Agrewala JN, Kulkarni SK,. Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur J Pharmacol 2000; 395: 15-21.
54. Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42.
55. Ambriz-Tututi M, Rocha-Gonzalez HI, Cruz SL, et al. Melatonin: a hormone that modulates pain. Life Sci 2009; 84: 489-498.
56. Olivier P, Fontaine RH, Loron G, et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS ONE 2009; 4: e7128.
57. Escames G, Leon J, Lopez LC, et al. Mechanisms of N-vmethyl-D-aspartate receptor inhibition by melatonin in the rat striatum. J Neuroendocrinol 2004; 16: 929-935.
58. Ebadi M, Govitrapong P, Phansuwan-Pujito P, et al. Pineal opioid receptors and analgesic action of melatonin. J Pineal Res 1998; 24: 193-200.
59. Kilic E, Ozdemir YG, Bolay H, et al. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 1999; 19: 511-516.
60. Tanuri FC, de LimaE, Peres MF, et al. Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin. J Headache Pain 2009; 10: 105-110.
61. Wang S, Zhang L, Lim G, et al. A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. Brain Res 2009; 1288: 42-49.
62. Kreutzberg GW,. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-318.
63. Eriksson NP, Persson JK, Aldskogius H, et al. A quantitative analysis of the glial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor in the adult rat. Exp Brain Res 1997; 114: 393-404.